a public good project by the
Synthesis
Company
of California

© 2026

Joan W. Miller | doi.page

0 works0 citations0 h-index

Joan W. Miller

Massachusetts Eye and Ear Infirmary(US)Harvard University(US)Retina Associates(US)

Publications by Year

Research Areas

Retinal Diseases and Treatments, Retinal Imaging and Analysis, Glaucoma and retinal disorders, Retinal and Optic Conditions, Retinal Development and Disorders

Most-Cited Works

→ Age-Related Macular Degeneration(2008)1,336 cited
→ Increased Vascular Endothelial Growth Factor Levels in the Vitreous of Eyes With Proliferative Diabetic Retinopathy(1994)1,290 cited
→ Intravitreous Injections of Vascular Endothelial Growth Factor Produce Retinal Ischemia and Microangiopathy in an Adult Primate(1996)520 cited
→ Genetic variants near TIMP3 and high-density lipoprotein–associated loci influence susceptibility to age-related macular degeneration(2010)511 cited
→ Tumor Necrosis Factor-α Mediates Oligodendrocyte Death and Delayed Retinal Ganglion Cell Loss in a Mouse Model of Glaucoma(2006)441 cited
→ VEGF164-mediated Inflammation Is Required for Pathological, but Not Physiological, Ischemia-induced Retinal Neovascularization(2003)421 cited

→ Vascular Endothelial Growth Factor A in Intraocular Vascular Disease(2012)402 cited

Diffusion of high molecular weight compounds through sclera.(2000)

→ Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia(2003)354 cited

Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model.(1994)